Related Experiment Video

Updated: Aug 13, 2026

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes
13:42

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes

Published on: March 8, 2013

[Prognostic value of antibodies anti-Chlamydia pneumoniae in ischemic heart disease]

C González Castañeda1, J L Pérez Castrillón, A Casero Lambas

  • 1Servicios de Medicina Interna y Cardiología, Hospital Universitario Río Hortega, Universidad de Valladolid, Valladolid.

Revista Clinica Espanola
|October 30, 2004
PubMed

Insights

Chlamydia pneumoniae antibodies were not associated with increased morbidity or mortality in patients with ischemic heart disease. Further research is needed to understand the role of this infection in cardiovascular prognosis.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Context:

  • Coronary artery disease (CAD) has been linked to Chlamydia pneumoniae infection.
  • Few studies have assessed the prognostic impact of anti-Chlamydia pneumoniae antibodies in ischemic heart disease (IHD) patients.
  • This study investigates the association between C. pneumoniae seropositivity and IHD outcomes.

Purpose:

  • To evaluate the impact of IgG anti-Chlamydia pneumoniae antibodies on morbidity and mortality in patients with ischemic heart disease.
  • To determine if C. pneumoniae seropositivity serves as a prognostic marker for IHD patients.

Summary:

  • 249 IHD patients (myocardial infarction, unstable angina, stable angina) were followed for 3 years.
  • IgG anti-C. pneumoniae antibodies were measured; positive serology was observed in 43% of myocardial infarction, 42% of unstable angina, and 58% of stable angina patients.
  • While initial analysis suggested a survival benefit in myocardial infarction patients with positive serology, logistic regression indicated age, not serology, was the significant predictor of mortality. No significant association was found for morbidity or mortality in unstable or stable angina groups.

Impact:

  • The presence of IgG antibodies to C. pneumoniae does not appear to be a reliable marker for predicting morbidity and mortality in this IHD patient cohort.
  • Findings suggest that the role of C. pneumoniae infection in the prognosis of ischemic heart disease requires further investigation.
  • This research contributes to understanding the complex relationship between infectious agents and cardiovascular disease outcomes.
Abstract

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...